FR23C1050I1 - Compose d'alkynylbenzene 3,5-disubstitue et un sel de celui-ci - Google Patents
Compose d'alkynylbenzene 3,5-disubstitue et un sel de celui-ciInfo
- Publication number
- FR23C1050I1 FR23C1050I1 FR23C1050C FR23C1050C FR23C1050I1 FR 23C1050 I1 FR23C1050 I1 FR 23C1050I1 FR 23C1050 C FR23C1050 C FR 23C1050C FR 23C1050 C FR23C1050 C FR 23C1050C FR 23C1050 I1 FR23C1050 I1 FR 23C1050I1
- Authority
- FR
- France
- Prior art keywords
- alkynylbenzene
- disubstituted
- salt
- disubstituted alkynylbenzene
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 150000003839 salts Chemical class 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Hematology (AREA)
- Oncology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pyridine Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2012009467 | 2012-01-19 | ||
PCT/JP2013/050740 WO2013108809A1 (fr) | 2012-01-19 | 2013-01-17 | Composé d'alkynylbenzène 3,5-disubstitué et un sel de celui-ci |
Publications (1)
Publication Number | Publication Date |
---|---|
FR23C1050I1 true FR23C1050I1 (fr) | 2024-01-26 |
Family
ID=48799233
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FR23C1050C Active FR23C1050I1 (fr) | 2012-01-19 | 2023-12-19 | Compose d'alkynylbenzene 3,5-disubstitue et un sel de celui-ci |
Country Status (24)
Country | Link |
---|---|
US (1) | US9108973B2 (fr) |
EP (1) | EP2657233B1 (fr) |
JP (1) | JP5355825B1 (fr) |
KR (1) | KR101623286B1 (fr) |
CN (1) | CN103958512B (fr) |
AU (1) | AU2013210403B2 (fr) |
BR (1) | BR112014017749B1 (fr) |
CA (1) | CA2854093C (fr) |
DK (1) | DK2657233T3 (fr) |
ES (1) | ES2516392T3 (fr) |
FI (1) | FIC20230038I1 (fr) |
FR (1) | FR23C1050I1 (fr) |
HK (1) | HK1198164A1 (fr) |
HU (1) | HUS2300043I1 (fr) |
MX (1) | MX351513B (fr) |
MY (1) | MY171055A (fr) |
NL (1) | NL301254I2 (fr) |
NO (1) | NO2023046I1 (fr) |
PL (1) | PL2657233T3 (fr) |
PT (1) | PT2657233E (fr) |
RU (1) | RU2576384C1 (fr) |
SG (1) | SG2014009286A (fr) |
TW (1) | TWI508964B (fr) |
WO (1) | WO2013108809A1 (fr) |
Families Citing this family (68)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2012088266A2 (fr) | 2010-12-22 | 2012-06-28 | Incyte Corporation | Imidazopyridazines et benzimidazoles substitués en tant qu'inhibiteurs de fgfr3 |
JP5873656B2 (ja) | 2011-06-13 | 2016-03-01 | 株式会社Ihi | 金属サレン錯体化合物、局所麻酔薬剤及び抗悪性腫瘍薬剤 |
CN107652289B (zh) | 2012-06-13 | 2020-07-21 | 因塞特控股公司 | 作为fgfr抑制剂的取代的三环化合物 |
SG11201500125QA (en) | 2012-07-11 | 2015-02-27 | Blueprint Medicines Corp | Inhibitors of the fibroblast growth factor receptor |
WO2014026125A1 (fr) | 2012-08-10 | 2014-02-13 | Incyte Corporation | Dérivés de pyrazine en tant qu'inhibiteurs de fgfr |
US9266892B2 (en) | 2012-12-19 | 2016-02-23 | Incyte Holdings Corporation | Fused pyrazoles as FGFR inhibitors |
AR094812A1 (es) | 2013-02-20 | 2015-08-26 | Eisai R&D Man Co Ltd | Derivado de piridina monocíclico como inhibidor del fgfr |
JP6449244B2 (ja) | 2013-04-19 | 2019-01-09 | インサイト・ホールディングス・コーポレイションIncyte Holdings Corporation | Fgfr抑制剤としての二環式複素環 |
US10124003B2 (en) * | 2013-07-18 | 2018-11-13 | Taiho Pharmaceutical Co., Ltd. | Therapeutic agent for FGFR inhibitor-resistant cancer |
PT3023100T (pt) * | 2013-07-18 | 2019-05-29 | Taiho Pharmaceutical Co Ltd | Fármaco antitumoral para administração intermitente de inibidor de fgfr |
JP6035423B2 (ja) | 2013-08-12 | 2016-11-30 | 大鵬薬品工業株式会社 | 新規な縮合ピリミジン化合物又はその塩 |
US9434700B2 (en) | 2013-10-25 | 2016-09-06 | Neil Bifulco, JR. | Inhibitors of the fibroblast growth factor receptor |
ES2756175T3 (es) | 2013-12-27 | 2020-04-27 | Chugai Pharmaceutical Co Ltd | Genes mutantes guardián de fgfr y fármacos que se dirigen a los mismos |
WO2015108992A1 (fr) | 2014-01-15 | 2015-07-23 | Blueprint Medicines Corporation | Composés hétérobicycliques et leur utilisation en tant qu'inhibiteurs du récepteur fgfr4 |
US9963456B2 (en) * | 2014-06-24 | 2018-05-08 | Taiho Pharmaceutical Co., Ltd | Pyrrolopyrimidine compound or salt thereof and compositions containing the pyrrolopyrimidine compound or salt thereof |
JP5925978B1 (ja) | 2014-08-18 | 2016-05-25 | エーザイ・アール・アンド・ディー・マネジメント株式会社 | 単環ピリジン誘導体の塩およびその結晶 |
US10851105B2 (en) | 2014-10-22 | 2020-12-01 | Incyte Corporation | Bicyclic heterocycles as FGFR4 inhibitors |
CN105837575B (zh) * | 2015-01-13 | 2019-01-15 | 四川大学 | 3-乙炔基吡唑并嘧啶衍生物及其制备方法和用途 |
BR112017016278B1 (pt) * | 2015-01-30 | 2022-05-10 | Taiho Pharmaceutical Co., Ltd | Uso de um composto com atividade inibitória de btk ou um sal deste para produzir um agente preventivo e/ou terapêutico para a prevenção ou tratamento de uma doença imune |
US9580423B2 (en) | 2015-02-20 | 2017-02-28 | Incyte Corporation | Bicyclic heterocycles as FGFR4 inhibitors |
WO2016134320A1 (fr) | 2015-02-20 | 2016-08-25 | Incyte Corporation | Hétérocycles bicycliques utilisés en tant qu'inhibiteurs de fgfr |
MA41551A (fr) | 2015-02-20 | 2017-12-26 | Incyte Corp | Hétérocycles bicycliques utilisés en tant qu'inhibiteurs de fgfr4 |
SG11201707384YA (en) * | 2015-03-31 | 2017-10-30 | Taiho Pharmaceutical Co Ltd | Crystal of 3,5-disubstituted benzene alkynyl compound |
US10479780B2 (en) | 2015-06-17 | 2019-11-19 | Chugai Seiyaku Kabushiki Kaisha | Aminopyrazole derivatives |
JP6141568B1 (ja) * | 2015-09-01 | 2017-06-07 | 大鵬薬品工業株式会社 | 新規なピラゾロ[3,4−d]ピリミジン化合物又はその塩 |
TWI623316B (zh) * | 2015-12-22 | 2018-05-11 | Taiho Pharmaceutical Co Ltd | Antitumor effect enhancer derived from pyrrolopyrimidine compound |
PT3269370T (pt) * | 2016-02-23 | 2020-03-05 | Taiho Pharmaceutical Co Ltd | Novo composto de pirimidina condensada ou sal do mesmo |
KR20240014585A (ko) | 2016-03-04 | 2024-02-01 | 다이호야쿠힌고교 가부시키가이샤 | 악성 종양 치료용 제제 및 조성물 |
US11883404B2 (en) | 2016-03-04 | 2024-01-30 | Taiho Pharmaceuticals Co., Ltd. | Preparation and composition for treatment of malignant tumors |
CN107344940B (zh) * | 2016-05-06 | 2020-04-21 | 广东东阳光药业有限公司 | Btk抑制剂及其用途 |
CN107698593A (zh) | 2016-08-09 | 2018-02-16 | 南京天印健华医药科技有限公司 | 作为fgfr抑制剂的杂环化合物 |
MA47696A (fr) | 2017-02-28 | 2020-01-08 | Taiho Pharmaceutical Co Ltd | Activateur d'effet antitumoral utilisant un composé pyrazolo[3,4-d]pyrimidine |
AR111960A1 (es) | 2017-05-26 | 2019-09-04 | Incyte Corp | Formas cristalinas de un inhibidor de fgfr y procesos para su preparación |
JOP20180094A1 (ar) | 2017-10-18 | 2019-04-18 | Hk Inno N Corp | مركب حلقي غير متجانس كمثبط بروتين كيناز |
CN109776544B (zh) * | 2017-11-15 | 2022-02-01 | 上海医药工业研究院 | 吡唑并[3,4-d]嘧啶类化合物及其制备方法和用途 |
WO2019181876A1 (fr) | 2018-03-19 | 2019-09-26 | 大鵬薬品工業株式会社 | Composition pharmaceutique comprenant du sulfate d'alkyle de sodium |
MX2020008610A (es) | 2018-03-28 | 2020-09-21 | Eisai R&D Man Co Ltd | Agente terapeutico para carcinoma hepatocelular. |
DK3788047T3 (da) | 2018-05-04 | 2024-09-16 | Incyte Corp | Faste former af en FGFR-inhibitor og fremgangsmåder til fremstilling deraf |
SG11202010882XA (en) | 2018-05-04 | 2020-11-27 | Incyte Corp | Salts of an fgfr inhibitor |
WO2020007234A1 (fr) * | 2018-07-02 | 2020-01-09 | 深圳市塔吉瑞生物医药有限公司 | Composé alcynyl(hétéro)aromatique pour l'inhibition de l'activité de protéine kinase |
KR20210088651A (ko) | 2018-11-09 | 2021-07-14 | 다이호야쿠힌고교 가부시키가이샤 | 디메톡시벤젠 화합물의 제조 방법 |
EP3882248A4 (fr) * | 2018-11-09 | 2022-07-06 | Taiho Pharmaceutical Co., Ltd. | Analogues de composés de diméthoxybenzène, procédés d'analyse desdits composés et produits standard desdits composés |
US20220023300A1 (en) * | 2018-11-26 | 2022-01-27 | Taiho Pharmaceutical Co., Ltd. | Therapeutic and prophylactic method for tumor treatable with endocrine therapy by combined use of fibroblast growth factor receptor inhibitor with endocrine therapy |
WO2020170355A1 (fr) * | 2019-02-20 | 2020-08-27 | 大鵬薬品工業株式会社 | Procede pour le traitement de tumeurs a variant du fgfr1 |
WO2020175704A1 (fr) * | 2019-02-28 | 2020-09-03 | 大鵬薬品工業株式会社 | Cancérothérapie utilisant un composé d'alcynyle benzène 3,5-disubstitué et un inhibiteur de point de contrôle immunitaire |
US11628162B2 (en) | 2019-03-08 | 2023-04-18 | Incyte Corporation | Methods of treating cancer with an FGFR inhibitor |
CN114364798A (zh) | 2019-03-21 | 2022-04-15 | 欧恩科斯欧公司 | 用于治疗癌症的Dbait分子与激酶抑制剂的组合 |
AU2020274083A1 (en) * | 2019-05-13 | 2021-11-18 | D.E. Shaw Research, Llc | FGFR inhibitors and methods of use thereof |
CA3139161A1 (fr) * | 2019-05-17 | 2020-11-26 | Kinnate Biopharma Inc. | Inhibiteurs des kinases du recepteur du facteur de croissance des fibroblastes |
AU2020297166A1 (en) | 2019-06-21 | 2022-02-17 | Taiho Pharmaceutical Co., Ltd. | Method for treating malignant tumor |
WO2021007269A1 (fr) | 2019-07-09 | 2021-01-14 | Incyte Corporation | Hétérocycles bicycliques en tant qu'inhibiteurs de fgfr |
MX2022004513A (es) | 2019-10-14 | 2022-07-19 | Incyte Corp | Heterociclos biciclicos como inhibidores de los receptores del factor de crecimiento de fibroblastos (fgfr). |
WO2021076728A1 (fr) | 2019-10-16 | 2021-04-22 | Incyte Corporation | Hétérocycles bicycliques en tant qu'inhibiteurs de fgfr |
WO2021089791A1 (fr) | 2019-11-08 | 2021-05-14 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Méthodes pour le traitement de cancers qui ont acquis une résistance aux inhibiteurs de kinase |
WO2021089005A1 (fr) * | 2019-11-08 | 2021-05-14 | 石药集团中奇制药技术(石家庄)有限公司 | Utilisation d'un inhibiteur de fgfr |
BR112022010664A2 (pt) | 2019-12-04 | 2022-08-16 | Incyte Corp | Derivados de um inibidor de fgfr |
JP2023505258A (ja) | 2019-12-04 | 2023-02-08 | インサイト・コーポレイション | Fgfr阻害剤としての三環式複素環 |
US12012409B2 (en) | 2020-01-15 | 2024-06-18 | Incyte Corporation | Bicyclic heterocycles as FGFR inhibitors |
WO2021148581A1 (fr) | 2020-01-22 | 2021-07-29 | Onxeo | Nouvelle molécule dbait et son utilisation |
JPWO2021153703A1 (fr) | 2020-01-31 | 2021-08-05 | ||
EP4183395A4 (fr) * | 2020-07-15 | 2024-07-24 | Taiho Pharmaceutical Co Ltd | Combinaison contenant un composé pyrimidine destinée à être utilisée dans le traitement de tumeurs |
TWI797711B (zh) * | 2020-08-13 | 2023-04-01 | 大陸商上海和譽生物醫藥科技有限公司 | 一種fgfr及其突變抑制劑,其製備方法和應用 |
WO2022042613A1 (fr) * | 2020-08-27 | 2022-03-03 | 上海和誉生物医药科技有限公司 | Dérivé de 1h-pyrazol-4-amide, son procédé de préparation et son utilisation |
CN114805359B (zh) * | 2021-01-28 | 2023-10-27 | 药雅科技(上海)有限公司 | 炔代杂环化合物fgfr抑制剂的制备方法和用途 |
CN115028634B (zh) * | 2021-03-08 | 2023-11-28 | 药雅科技(上海)有限公司 | 一种炔代吡嗪并杂环类fgfr抑制剂及其制备方法和用途 |
EP4323405A1 (fr) | 2021-04-12 | 2024-02-21 | Incyte Corporation | Polythérapie comprenant un inhibiteur de fgfr et un agent de ciblage de nectine-4 |
CA3220274A1 (fr) | 2021-06-09 | 2022-12-15 | Incyte Corporation | Heterocycles tricycliques en tant qu'inhibiteurs de fgfr |
CN115785103A (zh) * | 2022-12-28 | 2023-03-14 | 北京康立生医药技术开发有限公司 | 一种治疗胆管癌药物福巴替尼的合成方法 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2007087395A2 (fr) * | 2006-01-25 | 2007-08-02 | Osi Pharmaceuticals, Inc. | INHIBITEURS DE mTOR INSATURES |
EP2954900A1 (fr) * | 2007-03-28 | 2015-12-16 | Pharmacyclics, Inc. | Inhibiteurs de la tyrosine-kinase de bruton |
GB0819105D0 (en) * | 2008-10-17 | 2008-11-26 | Chroma Therapeutics Ltd | Pyrrolo-pyrimidine compounds |
KR101483215B1 (ko) | 2010-01-29 | 2015-01-16 | 한미약품 주식회사 | 단백질 키나아제 저해활성을 갖는 비시클릭 헤테로아릴 유도체 |
CA3113343A1 (fr) * | 2010-06-03 | 2011-12-08 | Pharmacyclics Llc | Utilisation d'inhibiteurs de la tyrosine-kinase de bruton dans le traitement du lymphome folliculaire |
-
2013
- 2013-01-17 WO PCT/JP2013/050740 patent/WO2013108809A1/fr active Application Filing
- 2013-01-17 ES ES13728918.7T patent/ES2516392T3/es active Active
- 2013-01-17 MY MYPI2014700531A patent/MY171055A/en unknown
- 2013-01-17 KR KR1020147013608A patent/KR101623286B1/ko active IP Right Grant
- 2013-01-17 PL PL13728918T patent/PL2657233T3/pl unknown
- 2013-01-17 PT PT137289187T patent/PT2657233E/pt unknown
- 2013-01-17 AU AU2013210403A patent/AU2013210403B2/en active Active
- 2013-01-17 EP EP13728918.7A patent/EP2657233B1/fr active Active
- 2013-01-17 SG SG2014009286A patent/SG2014009286A/en unknown
- 2013-01-17 BR BR112014017749-0A patent/BR112014017749B1/pt active IP Right Grant
- 2013-01-17 US US14/344,935 patent/US9108973B2/en active Active
- 2013-01-17 RU RU2014133907/04A patent/RU2576384C1/ru active
- 2013-01-17 DK DK13728918.7T patent/DK2657233T3/da active
- 2013-01-17 CA CA2854093A patent/CA2854093C/fr active Active
- 2013-01-17 MX MX2014008605A patent/MX351513B/es active IP Right Grant
- 2013-01-17 JP JP2013523428A patent/JP5355825B1/ja active Active
- 2013-01-17 CN CN201380003870.8A patent/CN103958512B/zh active Active
- 2013-01-18 TW TW102102005A patent/TWI508964B/zh active
-
2014
- 2014-11-18 HK HK14111639.8A patent/HK1198164A1/zh unknown
-
2023
- 2023-12-18 NL NL301254C patent/NL301254I2/nl unknown
- 2023-12-18 FI FIC20230038C patent/FIC20230038I1/fi unknown
- 2023-12-19 FR FR23C1050C patent/FR23C1050I1/fr active Active
- 2023-12-20 NO NO2023046C patent/NO2023046I1/no unknown
- 2023-12-21 HU HUS2300043C patent/HUS2300043I1/hu unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FR23C1050I1 (fr) | Compose d'alkynylbenzene 3,5-disubstitue et un sel de celui-ci | |
NO2022010I1 (no) | ripretinib, or a pharmaceutically acceptable salt thereof | |
BR302012005333S1 (pt) | "configuração aplicada em tampa". | |
FR2985500B1 (fr) | Configuration d'helicoptere | |
FR2994831B1 (fr) | Prothese de main. | |
CL2014003459A1 (es) | Compuestos fungicidas heterocíclicos. | |
FR2984087B1 (fr) | Element d'application cosmetique. | |
CL2014002034A1 (es) | Compuestos derivados de isoxazol-fenil-azetidina fenil sustituidos; y compuestos intermediarios. | |
IT1398747B1 (it) | Oscillatore. | |
PL2817297T3 (pl) | Sulfinyloaminobenzamidy skuteczne chwastobójczo | |
BR112013031570A2 (pt) | inalador de pó seco. | |
CL2015001192A1 (es) | Composición herbicida | |
BR112014027025A2 (pt) | composição cosmética. | |
FR2991704B1 (fr) | Coffrage d'ouverture | |
BR302012006162S1 (pt) | "configuração aplicada em cartucho" | |
FR2990456B1 (fr) | Marche d'escalier prefabriquee | |
FR2987772B1 (fr) | Chargeur d'etuis robotise | |
FR2992202B1 (fr) | Emulsion directe cosmetique. | |
TH1501000684B (th) | กระบวยรับสิ่งมีชีวิตแต่ละตัว | |
BR302012003604S1 (pt) | "configuração aplicada em cápsula" | |
BR302012003605S1 (pt) | "configuração aplicada em cápsula" | |
ITRM20130075A1 (it) | "mattone semipieno" | |
BR302012003277S1 (pt) | "configuração aplicada em tampa" | |
UA25723S (uk) | Іграшка м'яконабивна «тигрик» | |
BR302012005087S1 (pt) | "configuração aplicada em recipiente" |